Annual report pursuant to Section 13 and 15(d)

STOCK-BASED COMPENSATION (Tables)

v3.24.0.1
STOCK-BASED COMPENSATION (Tables)
12 Months Ended
Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]  
Schedule of time based stock options

The following table summarizes the activities for our stock options with time based vesting for the years ended December 31, 2023, and 2022.

 

    December 31,  
    2023   2022  
               
Dividend yield     0.00%     0.00%  
Expected Volatility     51.9% - 61.3%     65.29% - 77.5%  
Weighted-average volatility          
Expected dividends          
Expected term (in years)     10     10  
Risk-free rate     3.50% - 4.53%     1.81% - 4.02%  
Schedule of status of time based stock options

The following table summarizes the status of the time-based stock options:

 

    Years Ended December 31,  
    2023   2022  
    Shares   Weighted
Average
Exercise
Price
  Shares   Weighted
Average
Exercise
Price
 
                   
Outstanding at January 1   3,035,000   $ 3.93   3,672,500   $ 3.42  
Granted   430,000   $ 2.66   920,000   $ 2.62  
Exercised     $   1,031,250   $ 1.57  
Forfeited   208,750   $ 5.45   526,250   $ 2.73  
Outstanding at December 31   3,256,250   $ 3.66   3,035,000   $ 3.93  
Options exercisable at December 31   1,458,750   $ 4.42   737,500   $ 4.93  
Weighted average fair value of options granted during the period     $ 1.84     $ 1.99  
Stock-based compensation expense     $ 1,940,720     $ 2,083,397  
Schedule of information pertaining to options outstanding

The following table presents information pertaining to time- based stock options outstanding at December 31, 2023:

 

Range of Exercise Price   Number
Outstanding
  Weighted
Average
Remaining
Contractual
Life
  Weighted
Average
Exercise
Price
  Number
Exercisable
  Weighted
Average
Exercise
Price
 
                           
$2.18-$9.49   3,256,250   8.3 years   $ 3.66   1,458,750   $ 4.42  
The following table summarizes the activities for our unvested performance stock option awards for the twelve months ended December 31, 2023, and 2022.

Pursuant to an employment agreement entered into on November 6, 2023, with the Company’s Chief Commercial Officer, and as an inducement to his employment, the Company issued a non-qualified option to purchase 200,000 shares of common stock that vest upon achievement of sales growth milestones. The following table summarizes the activities for our unvested performance stock option awards for the twelve months ended December 31, 2023, and 2022.

 

    Twelve Months Ended December 31,  
    2023   2022  
    Shares   Weighted
Average
Grant-Date
Fair Value
  Shares   Weighted
Average
Grant-Date
Fair Value
 
                   
Unvested at January 1     $     $  
Granted   200,000   $ 1.48     $  
Vested     $     $  
Forfeited/canceled     $     $  
Unvested at December 31   200,000   $ 1.48     $  
The following table summarizes the activities for our unvested restricted stock awards for the twelve months ended December 31, 2023, and 2022.

The following table summarizes the activities for our unvested restricted stock awards for the twelve months ended December 31, 2023, and 2022.

 

    Twelve Months Ended December 31,  
    2023   2022  
    Shares   Weighted
Average
Grant-Date
Fair Value
  Shares   Weighted
Average
Grant-Date
Fair Value
 
                   
Unvested at January 1   950,000   $ 3.04   1,000,000   $ 3.01  
Granted   54,496   $ 3.68     $  
Vested   100,000   $ 3.31   50,000   $ 3.31  
Forfeited/canceled     $     $  
Unvested at December 31   904,496   $ 2.77   950,000   $ 3.04